Search Patents
  • Antiviral Face Mask
    Publication number: 20210368890
    Abstract: Disclosed herein are washable, reusable, antimicrobial and antiviral face masks and methods of their use for the reduction of transmission of infectious pathogens. Exemplary face masks are made of silver-coated material wherein activation of the silver from moisture in a user's breath kills pathogens. The disclosed face masks are useful in reducing, inhibiting or killing pathogens, such as SARS-CoV-2, that contact the face mask within 2 hours of continuous contact.
    Type: Application
    Filed: June 2, 2020
    Publication date: December 2, 2021
    Inventor: Raul BRIZUELA
  • ZINC AND COPPER FOR THE PROPHYLAXIS AND TREATMENT OF COVID-19
    Publication number: 20210322469
    Abstract: This disclosure describes methods for prophylaxis and treatment of coronavirus in vulnerable populations and infected individuals. The methods include the administration of zinc and in some embodiments copper. In some embodiments, an amount of zinc is administered sufficient to raise serum zinc levels to 60 ?g/dL. In some aspects, the coronavirus is the SARS-CoV-2 virus and/or the infection is COVID-19.
    Type: Application
    Filed: April 20, 2021
    Publication date: October 21, 2021
    Inventors: Fredericus J. van Kuijk, Scott W. McPherson
  • VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS
    Publication number: 20210353741
    Abstract: The present disclosure provides compositions and methods useful for preventing and/or treating coronavirus infection. As described herein, the compositions and methods are based on development of immunogenic compositions that include virus-like particles (VLPs) which comprise one or more Moloney Murine leukemia virus (MMLV) core proteins and include one or more coronavirus epitopes, such as, for example, from SARS-Cov-2 spike protein.
    Type: Application
    Filed: March 30, 2021
    Publication date: November 18, 2021
    Inventors: David Evander Anderson, Anne-Catherine Fluckiger
  • TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTION
    Publication number: 20220296676
    Abstract: A method of treating or preventing a Coronaviridae infection in a subject comprising administrating a therapeutically effective amount of a compound of Formula I or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the Coronaviridae comprises at least one selected from 2019-nCov virus, HCov 229E virus, SARS virus, MERS virus,
    Type: Application
    Filed: June 4, 2020
    Publication date: September 22, 2022
    Inventors: Jian CUI, Minglong HU, Yao YU, Along ZHAO, Faming ZHANG
  • SATELLITE BORNE SYNTHETIC APERTURE RADAR
    Publication number: 20210088651
    Abstract: The example non-limiting technology herein provides a Synthetic Aperture Radar (SAR) solution on board a micro-satellite that provides global revisit within 1 month; a cost below US$ 10 million; and satellite mass lower than 100 kg. One solution uses an inflatable Cassegrain type antenna with a phased beam steering array in the 1.2 GHz band.
    Type: Application
    Filed: September 20, 2019
    Publication date: March 25, 2021
    Inventors: João Roberto Moreira NETO, Janio KONO
  • USE OF 4-AMINOQUINOLINE COMPOUND IN TREATMENT OF CORONAVIRUS INFECTION
    Publication number: 20230218606
    Abstract: Disclosed are hydroxychloroquine or chloroquine, or a geometric isomer thereof, or a pharmaceutically acceptable salt thereof, and/or a solvate thereof, and/or a hydrate thereof, and a pharmaceutical composition containing the above-mentioned compound, and the use thereof in the treatment of diseases or infections caused by SARS-CoV-2.
    Type: Application
    Filed: June 2, 2020
    Publication date: July 13, 2023
    Inventors: Wu Zhong, Gengfu Xiao, Zhihong Hu, Manli Wang, Leike Zhang, Ruiyuan Cao, Wei Li, Shiyong Fan, Xinbo Zhou, Song Li
  • Apparatus for rocking a seat
    Publication number: 20180352970
    Abstract: An apparatus for rocking a piece of furniture to which it is attached. The rocking apparatus includes at least one rolling mechanism that, when in operation, rotates the rolling mechanism around an axis of rotation causing a rocking action. The apparatus may be utilized for rocking a variety of pieces of furniture such as a safety infant car seat, a stroller seat, a rocking chair, a swing or a hammock. According to some embodiments the rolling mechanism is connected to a driving portion.
    Type: Application
    Filed: August 15, 2018
    Publication date: December 13, 2018
    Inventor: Sar-el Israel
  • Use of Inhibitors of the Renin-Angiotensin System for the Treatment of Lung Injuries
    Publication number: 20080159962
    Abstract: The invention relates to the use of Angiotensin Converting enzyme 2 (ACE2) for the preparation of a medicament for the treatment of severe acute lung injury, especially induced by acid aspiration or sepsis, of lung oedemas and lung injuries and failures connected with infection with severe acute respiratory Syndrome (SARS) Coronavirus.
    Type: Application
    Filed: May 19, 2006
    Publication date: July 3, 2008
    Applicant: IMBA-INSTITUTE FUR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef Penninger, Yumiko Imai, Keiji Kuba, Chengyu Jiang
  • METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
    Publication number: 20230111947
    Abstract: Methods for prophylaxis, treatment, and reduction of infection, re-infection, and transmission rates of Coronaviruses and more particularly Coronavirus Disease 2019 (COVID-19) resulting from a SARS-CoV-2 viral infection with the use of a pharmaceutical preparation comprising one or more coated or uncoated digestive enzymes, such as pancreatic enzymes and porcine pancreatic enzymes are described herein.
    Type: Application
    Filed: December 8, 2022
    Publication date: April 13, 2023
    Inventors: Joan M. FALLON, Matthew HEIL, James J. FALLON, Janice HUGHES
  • BLOCKADE OF SARS-COV-2 INFECTION USING HYDROCARBON STAPLED PEPTIDES
    Publication number: 20240052330
    Abstract: The disclosure is directed to methods of inhibiting coronavirus infection using a hydrocarbon stapled peptide which is a peptidomimetic of the human angiotensin-converting enzyme 2 (hACE2). The hydrocarbon stapled peptide binds to the receptor binding domain (RBD) of a coronavirus spike protein (S) and inhibits binding of the coronavirus to hACE2 expressed on the surface of host cells.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 15, 2024
    Inventors: Yu TIAN, Sicheng JIANG, Jeffrey A. HUBBELL, Matthew A. TIRRELL, James L. LABELLE
  • METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION
    Publication number: 20230183323
    Abstract: Covid-19 is caused by a highly transmissible novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a variant thereof. Current available therapeutic modalities have significant efficacy issues. Described herein are methods of preventing, reversing, and/or treating a Covid-19 infection by administering an inhibitor of CHI3L1.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 15, 2023
    Inventors: Jack A. ELIAS, Chun Geun LEE, Bing MA, Suchitra KAMLE, Changmin LEE
  • ANTIBODIES FOR THE TREATMENT AND PREVENTION OF COVID-19 AND EMERGING VARIANTS
    Publication number: 20240228594
    Abstract: The subject matter disclosed herein relates to a recombinant spike (S) protein from the B.1.351.2-7 variant of the SARS-CoV-2 virus, the DNA and RNA nucleotide sequences encoding the recombinant B.1.351.2-7 spike protein, and engineered antibodies that bind the B.1.351.2-7 spike protein and neutralize the B.1.351.2-7 virus.
    Type: Application
    Filed: April 27, 2022
    Publication date: July 11, 2024
    Inventors: David D. HO, Yaoxing HUANG, Manoj S. NAIR
  • Information Handling System Network Communication with Through Link Aggregation
    Publication number: 20190245810
    Abstract: A client information handling system application selectively communicates network packets simultaneously through plural network interfaces by leveraging network address translation at the network layer of the network packets. Network packets are distributed across the plural network interfaces to achieve desired network communication goals, such as bandwidth, data rates, quality of service, reliability and SAR requirements.
    Type: Application
    Filed: February 2, 2018
    Publication date: August 8, 2019
    Applicant: Dell Products L.P.
    Inventors: Sinem Gulbay, Kamal J. Koshy
  • USES OF TAXIFOLIN FOR RESPIRATORY HEALTH
    Publication number: 20230119141
    Abstract: The present disclosure provides methods for treating or preventing an infectious disease or condition, such as the COVID-19 virus (SARS-CoV-2), by administering a therapeutically effective amount of taxifolin to a subject in need thereof, wherein the taxifolin is administered to the subject in combination with a therapeutically effective amount of one or more additional therapeutic agents.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 20, 2023
    Inventors: Steven CHEN, Linda Shuo MAY-ZHANG
  • Uses and Formulations of Cannabinoids
    Publication number: 20230181484
    Abstract: Uses and formulations of cannabinoids, in particular of cannabidiol, are provided. The cannabinoids, in particular cannabidiol, are used for the treatment of patients suffering from COVID-19, a disease caused by the coronavirus SARS-Cov-2. Formulations are especially for oral administration of cannabinoids, in particular of cannabidiol. These formulations are useful for treating patients suffering from COVID-19.
    Type: Application
    Filed: May 11, 2020
    Publication date: June 15, 2023
    Applicant: ADD Advanced Drug Delivery Technologies Ltd.
    Inventors: Reinhard Nowak, Mirko Nowak, Jesko Jay Nowak, Norbert Pöllinger
  • Sar'-(OMe)Thr.sup.8 Angiotensin II as an angiotensin II antagonist
    Patent number: 3976770
    Abstract: A new octapeptide having profound angiotensin antagonist properties has been found. The new compound resembles angiotensin II except for the two terminal amino acids, carrying unnatural amino acids at the N-terminus, and at the C-terminus.
    Type: Grant
    Filed: February 10, 1975
    Date of Patent: August 24, 1976
    Inventors: Francis Merlin Bumpus, Mahesh Chandra Khosla, Robert Rudolph Smeby
  • SARS COV-2 SPIKE PROTEIN CONSTRUCT
    Publication number: 20230364219
    Abstract: Compounds useful as components of immunogenic compositions for the induction of an immunogenic response in a subject against infection, methods for their use in treatment, and processes for their manufacture are provided herein. The compounds comprise a nucleic acid construct comprising a sequence which encodes an antigen, in particular a Coronavirus antigen.
    Type: Application
    Filed: April 16, 2021
    Publication date: November 16, 2023
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Dong YU, Giulietta MARUGGI, Jason W. WESTERBECK, Jeffrey B. ULMER, Jason P. LALIBERTE, Kate LUISI, Lin QU
  • CATALYST FOR TREATING EXHAUST GAS
    Publication number: 20150265969
    Abstract: Provided is a method for reducing N2O emissions in an exhaust gas comprising contacting an exhaust gas containing NH3 and an inlet NO concentration with an SCR catalyst composition containing small pore zeolite having an SAR of about 3 to about 15 and having about 1-5 wt. % of an exchanged transition metal.
    Type: Application
    Filed: March 23, 2015
    Publication date: September 24, 2015
    Inventors: Joseph Michael FEDEYKO, Alexander Nicholas Michael GREEN, Guy Richard CHANDLER, Jillian Elaine COLLIER, Hai-Ying CHEN
  • Prediction of Severity of COVID-19 and Methods of Treatment
    Publication number: 20240369569
    Abstract: The invention relates generally to coronavirus disease 2019 (COVID-19) and more particularly to the prediction of severity of COVID-19 manifestation in a patient or in an individual at risk of infection by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) based on a level of chemokine (C-X-C motif) ligand 16 (CXCL 16) expression in and/or the rs 10490770 genotype of the patient or individual.
    Type: Application
    Filed: December 2, 2022
    Publication date: November 7, 2024
    Inventors: Sandra Smieszek, Vasilios Polymeropoulos, Christos Polymeropoulos, Bartlomiej Przychodzen, Mihael Polymeropoulos
  • METHOD FOR GENERATING CONTENT IN AN EXTENSIBLE MANNER
    Publication number: 20220019726
    Abstract: A communication method for communicating information through a telecommunications network. The telecommunications network comprises includes at least one server and at least one terminal exchanging a dataset. The terminal is configured so as to implement an Internet browser and the communication method is executed by the Internet browser. The communication method includes a step of analysing said dataset, which consists of at least one element from among: an object element, a branch element and a display element.
    Type: Application
    Filed: October 29, 2019
    Publication date: January 20, 2022
    Inventor: Somanos SAR
Narrow Results

Filter by US Classification